Accuvest Global Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Accuvest Global Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-214	Closed	-$14K	–	51
2019 Q4	$14K	Sell	214 -34	-14%	-$1.95K	0.03%	29
2019 Q3	$13K	Sell	248 -14,238	-98%	-$669K	0.03%	34
2019 Q2	$657K	Buy	+14,486	New	+$675K	0.38%	53
2018 Q4	–	Sell	-12,907	Closed	-$801K	–	116
2018 Q3	$801K	Sell	12,907 -4,099	-24%	-$243K	0.3%	58
2018 Q2	$941K	Buy	+17,006	New	+$918K	0.36%	44
2017 Q4	–	Sell	-85	Closed	-$5K	–	97
2017 Q3	$5K	Sell	85 -10,475	-99%	-$612K	﹤0.01%	66
2017 Q2	$588K	Buy	+10,560	New	+$575K	0.2%	49

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Accuvest Global Advisors's BMY Position: Q1 2020 in Review

Accuvest Global Advisors sold out of Bristol-Myers Squibb (BMY) in Q1 2020, closing a stake of 214 shares — an estimated $14K sold.

Accuvest Global Advisors first reported a position in BMY in Q2 2017 and held it in 7 quarters. The position peaked at $941K in Q2 2018. 2,148 funds tracked by Wall St. Rank hold BMY as of Q1 2020.

Accuvest Global Advisors reported no remaining Bristol-Myers Squibb position as of Q1 2020 after selling out during the quarter.
Accuvest Global Advisors sold 214 Bristol-Myers Squibb shares in Q1 2020, an estimated $14K.
Accuvest Global Advisors first reported a position in Bristol-Myers Squibb in Q2 2017 and held it in 7 quarters.
Accuvest Global Advisors's Bristol-Myers Squibb position peaked at $941K in Q2 2018.
2,148 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2020.

Based on Accuvest Global Advisors's 13F filing for Q1 2020, filed 23 Apr 2020.